BACKGROUND: Massive left ventricular hypertrophy (LVH) is a risk factor for sudden cardiac death in children with hypertrophic cardiomyopathy (HCM), but little is understood about its natural history.

Multicenter randomized trial (n=200) assigned LBBP versus BiVP for CRT in LBBB with LVEF ≤35%, using time to death or HF hospitalization as primary endpoint. Event rates favored LBBP, reducing death ...

Ancora Heart kicked off a European clinical study for its device designed to directly repair an enlarged left ventricle from the inside, as a treatment for patients suffering from heart failure. The ...

CHICAGO, IL — AUGMENT HF, a phase 2 trial of 78 patients with advanced heart failure, showed that an injection of the novel hydrogel Algisyl-LVR hydrogel (LoneStar Heart, Dallas, TX) into their left ...

Elevated left ventricular mass, known as left-ventricular hypertrophy, is a stronger predictor of coronary artery disease-related death and heart failure than coronary artery calcium score, according ...

Left bundle branch area pacing was found to be an effective and practical strategy for cardiac resynchronization, according ...

BioVentrix has collected $48.5 million in venture capital funding to help carry its treatment for ischemic heart failure to an FDA review. The former Fierce Medtech Fierce 15 winner’s minimally ...

Certain heart conditions, including a heart attack, may contribute to an enlarged heart. In these instances, a doctor may recommend left ventricular reconstructive surgery to prevent further ...

Ventricular resection is a type of open-heart surgery to reshape and resize the heart. The surgery may help to improve survival in people with heart failure. Ventricular resection is a surgical ...